Evidence map›Paper›PMID 16782881›Full record

ArticleMolecular and cellular biology2006

Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells.

Chrystelle V Garat, Dana Fankell, Paul F Erickson, Jane E-B Reusch, Natalie N Bauer, Ivan F McMurtry, Dwight J Klemm

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. What turns CREB on? And off? And why does it matter?Cellular and molecular life sciences : CMLS · 2020
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension.American journal of respiratory cell and molecular biology · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Beyond phosphorylation: nuclear export in vascular remodeling.Arteriosclerosis, thrombosis, and vascular biology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chrystelle V GaratCardiovascular Pulmonary Research, University of Colorado Health Sciences Center, 4200 East Ninth Ave., Campus Box B-133, Denver, CO 80262, USA.
Dana Fankell
Paul F Erickson
Jane E-B Reusch
Natalie N Bauer
Ivan F McMurtry
Dwight J Klemm
Pulmonary and Critical Care Associates · USUniversity of Colorado Health · USVeterans Health Administration · US

Funding

VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
NHLBI NIH HHS HL14985NHLBI NIH HHS P01 HL014985
6 · The paper itself

Abstract

Cyclic AMP response element binding protein (CREB) content is diminished in smooth muscle cells (SMCs) in remodeled pulmonary arteries from animals with pulmonary hypertension and in the SMC layers of atherogenic systemic arteries and cardiomyocytes from hypertensive individuals. Loss of CREB can be induced in cultured SMCs by chronic exposure to hypoxia or platelet-derived growth factor BB (PDGF-BB). Here we investigated the signaling pathways and mechanisms by which PDGF elicits depletion of SMC CREB. Chronic PDGF treatment increased CREB ubiquitination in SMCs, while treatment of SMCs with the proteasome inhibitor lactacystin prevented decreases in CREB content. The nuclear export inhibitor leptomycin B also prevented depletion of SMC CREB alone or in combination with lactacystin. Subsequent studies showed that PDGF activated extracellular signal-regulated kinase, Jun N-terminal protein kinase, and phosphatidylinositol 3 (PI3)-kinase pathways in SMCs. Inhibition of these pathways blocked SMC proliferation in response to PDGF, but only inhibition of PI3-kinase or its effector, Akt, blocked PDGF-induced CREB loss. Finally, chimeric proteins containing enhanced cyan fluorescent protein linked to wild-type CREB or CREB molecules with mutations in several recognized phosphorylation sites were introduced into SMCs. PDGF treatment reduced the levels of each of these chimeric proteins except for one containing mutations in adjacent serine residues (serines 103 and 107), suggesting that CREB loss was dependent on CREB phosphorylation at these sites. We conclude that PDGF stimulates nuclear export and proteasomal degradation of CREB in SMCs via PI3-kinase/Akt signaling. These results indicate that in addition to direct phosphorylation, proteolysis and intracellular localization are key mechanisms regulating CREB content and activity in SMCs.

Indexed as

AcetylcysteineActive Transport, Cell NucleusAnimalsBecaplerminCell ProliferationCyclic AMP Response Element-Binding ProteinCysteine Proteinase InhibitorsFatty Acids, UnsaturatedHumansMutationMyocytes, Smooth MusclePhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPhosphorylationPlatelet-Derived Growth FactorProteasome Endopeptidase ComplexAcetylcysteineBecaplerminCyclic AMP Response Element-Binding ProteinCysteine Proteinase InhibitorsFatty Acids, Unsaturatedlactacystinleptomycin BPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPlatelet-Derived Growth FactorProteasome Endopeptidase ComplexProteasome InhibitorsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-sisRecombinant Fusion ProteinsSerineUbiquitin

Identifiers

PMID16782881
PMCPMC1489168
OpenAlexW2127390296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.